SCHEMBL6322113

SCHEMBL6322113

CCCCNC(=O)c1c(-c2ccsc2)noc1NS(C)(=O)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.42
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HTT P42858 2/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
HIF1A Q16665 1/20 0.40
KMT2A Q03164 2/20 0.39
HPGD P15428 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PKM P14618 1/20 0.38
HDAC6 Q9UBN7 4/20 0.37
HDAC1 Q13547 3/20 0.37
HDAC3 O15379 3/20 0.37
NCOR2 Q9Y618 2/20 0.37
HDAC4 P56524 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
TRPV1 Q8NER1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6318154 0.88 GAA (0.46) GAAHTTTP53KMT2AL3MBTL1
SCHEMBL6318163 0.86 EDNRA (0.43) GAANPC1RAB9ASMN1; SMN2HTT
SCHEMBL6317516 0.86 L3MBTL1 (0.45) GAANPC1RAB9ASMN1; SMN2HTT
SCHEMBL6316801 0.84 ADORA1 (0.47) GAANPC1RAB9ASMN1; SMN2HTT
SCHEMBL6318504 0.83 GAA (0.42) GAANPC1RAB9ASMN1; SMN2HTT
SCHEMBL6316540 0.83 GAA (0.48) GAANPC1RAB9ASMN1; SMN2HTT
SCHEMBL6318223 0.82 GAA (0.48) GAANPC1RAB9ASMN1; SMN2HTT
SCHEMBL6317538 0.81 EDNRA (0.41) KMT2ATRPV1EDNRA
SCHEMBL6319331 0.81 HDAC3 (0.47) GAANPC1RAB9ASMN1; SMN2LMNA
SCHEMBL6318603 0.81 L3MBTL1 (0.47) GAAKMT2AL3MBTL1HDAC6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors PFIZER ITALIA S.R.L. (IT) 2005-03-17 US claimed
EP-1435948-A1 AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS Pharmacia Italia S.p.A. (IT) 2004-07-14 EP claimed
WO-2003013517-A1 AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS PHARMACIA ITALIA S.P.A. (IT) 2003-02-20 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050059657-A1 Aminoisoxazole derivatives active as kinase inhibitors MAP3K9, MAP3K19, MAP4K2 GAA 789/4885NPC1 3741/4885RAB9A 1754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.